Episode 8 - Dr Jakub Šimeček - CEO & Co-Founder

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/82/76/17/82761746-51b0-bb73-d9a4-166ce052cdf6/mza_8815142018224292619.jpg/600x600bb.jpg

Domus Search - The European BioTech, Pharma & MedTech C-Suite Leadership Podcast

Matt Grady - Partner

21 episodes

6 days ago

Topical industry and executive career discussions with C-Suite leaders, KOLs and Subject Matter Experts in BioTech, Pharma and MedTech, Private Equity and Venture Capital organisations across the European Healthcare Ecosystems. Find out more about Domus Search www.domus-search.com and www.linkedin.com/in/mattgrady/

Careers

Business

RSS

All content for Domus Search - The European BioTech, Pharma & MedTech C-Suite Leadership Podcast is the property of Matt Grady - Partner and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Careers

Business

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_episode/15116335/15116335-1665650358470-6d7b6ec87325a.jpg

Episode 8 - Dr Jakub Šimeček - CEO & Co-Founder - Trimt

Domus Search - The European BioTech, Pharma & MedTech C-Suite Leadership Podcast

29 minutes 41 seconds

3 years ago

Episode 8 - Dr Jakub Šimeček - CEO & Co-Founder - Trimt

I'm delighted to share that I sat down in conversation with TRIMT GmbH Co-Founder & Chief Executive Officer Jakub Šimeček, to record a video podcast on the Domus Search - Leadership Podcast this morning.

The Domus Search - Leadership Podcast offers a glimpse into the world of industry leaders through interactive conversations with CEO's, C-Suite Executives and Executive Leadership Teams across European BioTech, Pharma and MedTech sectors.

Domus Search is THE ONLY BioTech and MedTech Executive Search Firm with over 97% coverage of C-Suite Candidates in 45 European Countries (at any given time), and we are committed to sharing leadership insight with our European BioTech and Medtech network.

About my guest:

Jakub´s background in chemistry with the Charles University in Prague, radiopharmaceutical sciences (as visiting researcher at University of Helsinki and at Memorial Sloan Kettering Cancer Center, NY) and the development of targeted radiolabelled conjugates, their preclinical evaluation and transfer to first-in-human studies (doctoral degree at Technical University of Munich) resulted in different positions in the radiopharmaceutical industry after leaving the academia.

He has led various technical (small scale GMP production) and radiopharmaceutical projects toward establishing novel radiodiagnostic and radiotherapeutic applications (innovative Ga-68, Lu-177 and Ac-225 based APIs).

Learn more about TRIMT here - https://trimt.de/